GeneDx Holdings Corp’s filing revealed that its CHIEF EXECUTIVE OFFICER Stueland Katherine unloaded Company’s shares for reported $1.39 million on Sep 30 ’25. In the deal valued at $108.17 per share,12,858 shares were sold. As a result of this transaction, Stueland Katherine now holds 1,720 shares worth roughly $0.24 million.
Then, Feeley Kevin sold 6,609 shares, generating $716,261 in total proceeds. Upon selling the shares at $108.38, the CHIEF FINANCIAL OFFICER now owns 3,392 shares.
Before that, Kevin Feeley bought 5,805 shares. GeneDx Holdings Corp shares valued at $625,400 were divested by the Officer at a price of $107.73 per share.
Canaccord Genuity initiated its GeneDx Holdings Corp [WGS] rating to a Buy in a research note published on October 20, 2025; the price target was $155. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early July with a ‘”an Overweight”‘ rating. Guggenheim began covering WGS with “Buy” recommendation on May 15, 2025. Jefferies revised its rating on May 09, 2025. It rated WGS as “a Buy” which previously was an “a Hold”.
Price Performance Review of WGS
On Tuesday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock jump 5.21% to $137.47. Over the last five days, the stock has gained 12.89%. GeneDx Holdings Corp shares have risen nearly 132.65% since the year began. Nevertheless, the stocks have risen 78.86% over the past one year. While a 52-week high of $136.00 was reached on 10/28/25, a 52-week low of $55.17 was recorded on 05/08/25.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 123.65, which if violated will result in even more drops to 109.82. On the upside, there is a resistance level at 148.65. A further resistance level may holdings at 159.82.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2025-10-15, dropping by -0.61 million shares to a total of 3.0 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 3.61 million shares. There was a decline of -20.32%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 28, 2024 when Wells Fargo began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $34 price target.
